Literature DB >> 19387110

An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease.

Paula I Moreira1, Ana I Duarte, Maria S Santos, A Cristina Rego, Catarina R Oliveira.   

Abstract

The processes underlying the pathogenesis of Alzheimer's disease involve several factors including impaired glucose/energy metabolism, mitochondrial dysfunction, oxidative stress and altered insulin-signaling pathways. This review is mainly devoted to discuss evidence supporting the notion that mitochondrial dysfunction and oxidative stress are interconnected and intimately associated with the development and progression of Alzheimer's disease. Furthermore, the review explores the role of insulin signaling in the pathophysiology of the disease. Indeed, several studies have begun to find links between insulin and mechanisms with clear pathogenic implications for this disorder. Understanding the key mechanisms involved in the etiopathogenesis of Alzheimer's disease may provide opportunities for the design of efficacious preventive and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387110     DOI: 10.3233/JAD-2009-0972

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  56 in total

Review 1.  Calcium and mitochondrial reactive oxygen species generation: how to read the facts.

Authors:  Vera Adam-Vizi; Anatoly A Starkov
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.

Authors:  Sidharth Mehan; Harikesh Meena; Deepak Sharma; Rameshwar Sankhla
Journal:  J Mol Neurosci       Date:  2010-09-28       Impact factor: 3.444

3.  Treadmill Exercise Exerts Neuroprotection and Regulates Microglial Polarization and Oxidative Stress in a Streptozotocin-Induced Rat Model of Sporadic Alzheimer's Disease.

Authors:  Yujiao Lu; Yan Dong; Donovan Tucker; Ruimin Wang; Mohammad Ejaz Ahmed; Darrell Brann; Quanguang Zhang
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

Review 5.  The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.

Authors:  John Grizzanti; Hyoung-Gon Lee; Antoni Camins; Merce Pallas; Gemma Casadesus
Journal:  Nutr Res       Date:  2016-11-08       Impact factor: 3.315

6.  Low-level laser therapy for beta amyloid toxicity in rat hippocampus.

Authors:  Yujiao Lu; Ruimin Wang; Yan Dong; Donovan Tucker; Ningjun Zhao; Md Ejaz Ahmed; Ling Zhu; Timon Cheng-Yi Liu; Robert M Cohen; Quanguang Zhang
Journal:  Neurobiol Aging       Date:  2016-10-11       Impact factor: 4.673

Review 7.  Diabetes mellitus and cognitive impairments.

Authors:  Elham Saedi; Mohammad Reza Gheini; Firoozeh Faiz; Mohammad Ali Arami
Journal:  World J Diabetes       Date:  2016-09-15

Review 8.  Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Authors:  Cristina Carvalho; Sónia C Correia; Renato X Santos; Susana Cardoso; Paula I Moreira; Timothy A Clark; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

9.  Insulin promotes survival of amyloid-beta oligomers neuroblastoma damaged cells via caspase 9 inhibition and Hsp70 upregulation.

Authors:  M Di Carlo; P Picone; R Carrotta; D Giacomazza; P L San Biagio
Journal:  J Biomed Biotechnol       Date:  2010-05-13

10.  The S100B/RAGE Axis in Alzheimer's Disease.

Authors:  Estelle Leclerc; Emmanuel Sturchler; Stefan W Vetter
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.